This CTD dossier owner and manufacturer boasts state-of-the-art manufacturing facilities adhering to strict cGMP standards. Their production lines encompass prescription medications, targeting key therapy areas such as oncology, virology, central nervous system disorders, and hormone regulation. The facility houses a dedicated OEB-4 unit encompassing 96,000 sq. ft., equipped with advanced HVAC systems and stringent safety protocols to ensure zero contamination. They hold GMP certifications and are committed to delivering high-quality medicines across the EU and North America.